These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7086194)

  • 21. Intradermal Injections of Bleomycin to Model Skin Fibrosis.
    Yamamoto T
    Methods Mol Biol; 2017; 1627():43-47. PubMed ID: 28836193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connective tissue metabolism including cytokines in scleroderma.
    Smith EA
    Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
    Derk CT; Jimenez SA
    Autoimmun Rev; 2006 Jan; 5(1):25-32. PubMed ID: 16338208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiovascular manifestations of systemic sclerosis (scleroderma).
    Follansbee WP
    Curr Probl Cardiol; 1986 May; 11(5):241-98. PubMed ID: 3487417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal model of systemic sclerosis.
    Yamamoto T
    J Dermatol; 2010 Jan; 37(1):26-41. PubMed ID: 20175838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmunity and vascular involvement in systemic sclerosis (SSc).
    Kahaleh MB; LeRoy EC
    Autoimmunity; 1999; 31(3):195-214. PubMed ID: 10739336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.
    Feghali CA; Bost KL; Boulware DW; Levy LS
    J Rheumatol; 1992 Aug; 19(8):1207-11. PubMed ID: 1404155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
    Feghali CA; Boulware DW; Levy LS
    J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A radical proposal for the pathogenesis of scleroderma.
    Murrell DF
    J Am Acad Dermatol; 1993 Jan; 28(1):78-85. PubMed ID: 8425975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma).
    Nguyen VA; Sgonc R; Dietrich H; Wick G
    J Autoimmun; 2000 Mar; 14(2):143-9. PubMed ID: 10677245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast selection in scleroderma. An alternative model of fibrosis.
    Botstein GR; Sherer GK; Leroy EC
    Arthritis Rheum; 1982 Feb; 25(2):189-95. PubMed ID: 7066048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.
    Rossi A; Sozio F; Sestini P; Renzoni EA; Khan K; Denton CP; Abraham DJ; Weber E
    Hum Pathol; 2010 Mar; 41(3):366-74. PubMed ID: 20004944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of collagen production by traditional Chinese herbal medicine in scleroderma fibroblast cultures.
    Sheng FY; Ohta A; Yamaguchi M
    Intern Med; 1994 Aug; 33(8):466-71. PubMed ID: 7803912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial injury in scleroderma.
    Kahaleh MB; Sherer GK; LeRoy EC
    J Exp Med; 1979 Jun; 149(6):1326-35. PubMed ID: 312896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vascular basement membrane in systemic sclerosis skin: heterogeneity of type IV collagen.
    Hoyland JA; Newson L; Jayson MI; Freemont AJ
    Br J Dermatol; 1993 Oct; 129(4):384-8. PubMed ID: 8217749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
    Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
    Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
    J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.